Man Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-535,000
| Closed | -$15.9M | – | 2326 |
|
|
2023
Q4 | $15.9M | Buy |
+535,000
| New | +$10.7M | 0.04% | 485 |
|
|
2023
Q3 | – | Sell |
-682,227
| Closed | -$11.3M | – | 604 |
|
|
2023
Q2 | $12.9M | Buy |
+682,227
| New | +$8.05M | 0.04% | 538 |
|
|
2023
Q1 | – | Sell |
-215,762
| Closed | -$920K | – | 1485 |
|
|
2022
Q4 | $1.07M | Buy |
+215,762
| New | +$1.17M | ﹤0.01% | 1298 |
|
|
2021
Q1 | – | Sell |
-149,795
| Closed | -$966K | – | 2034 |
|
|
2020
Q4 | $966K | Sell |
149,795
-16,700
| -10% | -$97.4K | ﹤0.01% | 1426 |
|
|
2020
Q3 | $599K | Sell |
166,495
-2,400
| -1% | -$9.69K | ﹤0.01% | 1510 |
|
|
2020
Q2 | $777K | Sell |
168,895
-47,100
| -22% | -$200K | ﹤0.01% | 1344 |
|
|
2020
Q1 | $737K | Sell |
215,995
-11,500
| -5% | -$50.3K | ﹤0.01% | 1189 |
|
|
2019
Q4 | $1.16M | Sell |
227,495
-5,900
| -3% | -$20K | ﹤0.01% | 1475 |
|
|
2019
Q3 | $565K | Sell |
233,395
-211,660
| -48% | -$562K | ﹤0.01% | 1549 |
|
|
2019
Q2 | $966K | Sell |
445,055
-1,900
| -0.4% | -$4.49K | ﹤0.01% | 1541 |
|
|
2019
Q1 | $1.21M | Sell |
446,955
-3,600
| -0.8% | -$15.6K | ﹤0.01% | 1525 |
|
|
2018
Q4 | $2.16M | Buy |
450,555
+91,355
| +25% | +$554K | 0.01% | 1182 |
|
|
2018
Q3 | $3.4M | Buy |
359,200
+336,392
| +1,475% | +$3.23M | 0.01% | 1200 |
|
|
2018
Q2 | $222K | Buy |
+22,808
| New | +$240K | ﹤0.01% | 1986 |
|
Other funds holding IMGN
Man Group's IMGN Position: Q1 2024 in Review
Man Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 535,000 shares — an estimated $15.9M sold.
Man Group first reported a position in IMGN in Q2 2018 and held it in 14 quarters. The position peaked at $15.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Man Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Man Group sold 535,000 Immunogen Inc shares in Q1 2024, an estimated $15.9M.
- Man Group first reported a position in Immunogen Inc in Q2 2018 and held it in 14 quarters.
- Man Group's Immunogen Inc position peaked at $15.9M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.